Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Fiction
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/8f/64/f1/8f64f1da-90f8-79b7-6fd6-94a4891466de/mza_9104659715231042816.jpg/600x600bb.jpg
Society of Hematologic Oncology Insider news
Seriously simple podcasting
14 episodes
5 days ago
SOHO Insider delivers on the latest news in hematologic oncology and updates from the Society of Hematologic Oncology
Show more...
Life Sciences
Science
RSS
All content for Society of Hematologic Oncology Insider news is the property of Seriously simple podcasting and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
SOHO Insider delivers on the latest news in hematologic oncology and updates from the Society of Hematologic Oncology
Show more...
Life Sciences
Science
https://sohoinsider.com/wp-content/uploads/2025/04/SOHO_Insider_Podcast-0271.png
Drs. O’Brien, Jain discuss FLAIR trial, BTK degraders in CLL
Society of Hematologic Oncology Insider news
12 minutes 19 seconds
2 weeks ago
Drs. O’Brien, Jain discuss FLAIR trial, BTK degraders in CLL
In this episode of the SOHO Insider podcast, Susan O’Brien, MD, a professor of medicine from the Chao Family Comprehensive Cancer Center at the University of California, Irvine Medical Center, and Nitin Jain, MD, professor of medicine in the Department of Leukemia at the University of Texas MD Anderson Cancer Center, discuss updated results from the phase 3 FLAIR trial; the pair also speak about Bruton’s tyrosine kinase degraders in treating CLL.        
Society of Hematologic Oncology Insider news
SOHO Insider delivers on the latest news in hematologic oncology and updates from the Society of Hematologic Oncology